CCR5 and progressive multifocal leukoencephalopathy: To prevent an immune reconstitution inflammatory syndrome (IRIS), the patient received additionally maraviroc 600 mg/day, a CCR5 antagonist that seems beneficial in PML-IRIS (Hodecker et al. 2017).